Non-thyroidal illness syndrome predicts poor prognosis in hepatocellular carcinoma patients treated with atezolizumab and bevacizumab
非甲状腺疾病综合征预示着接受阿特珠单抗和贝伐珠单抗治疗的肝细胞癌患者预后不良
期刊:Cancer Immunology Immunotherapy
影响因子:5.1
doi:10.1007/s00262-026-04308-z
Chen, I-Wen; Lin, Cheng-Wei; Lin, Po-Ting; Teng, Wei; Su, Chung-Wei; Wu, Tsung-Han; Hsieh, Yi-Chung; Chen, Wei-Ting; Lin, Chen-Chun; Lin, Shi-Ming; Lin, Chun-Yen